Cargando…

Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia

Myelodysplasia refers to a group of clonal hematopoietic neoplasms characterized by genetic heterogeneity, different clinical behaviors and prognoses. Some of this group of bone marrow failure conditions have known external causes, some are of unknown origin. Within marrow, intracellular, and extrac...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kast, Richard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072867/ https://www.ncbi.nlm.nih.gov/pubmed/30101125 http://dx.doi.org/10.3389/fonc.2018.00280

Ejemplares similares

Methylene blue inhibits NLRP3, NLRC4, AIM2, and non-canonical inflammasome activation
por: Ahn, Huijeong, et al.
Publicado: (2017)

Methylene Blue Mitigates Acute Neuroinflammation after Spinal Cord Injury through Inhibiting NLRP3 Inflammasome Activation in Microglia
por: Lin, Zhi-Hang, et al.
Publicado: (2017)

Bone Marrow Immunity and Myelodysplasia
por: Lambert, Claude, et al.
Publicado: (2016)

Caffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome
por: Dai, Guoliang, et al.
Publicado: (2020)

Correlation Between the NLRP3 Inflammasome and the Prognosis of Patients With LSCC
por: Xue, Yi, et al.
Publicado: (2019)

Coffee reduces the risk of hepatocellular carcinoma probably through inhibition of NLRP3 inflammasome activation by caffeine
por: Fan, Frank S.
Publicado: (2022)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype
por: Sallman, David A., et al.
Publicado: (2016)

Inflammasome-Associated Gastric Tumorigenesis Is Independent of the NLRP3 Pattern Recognition Receptor
por: West, Alice J., et al.
Publicado: (2022)

Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients
por: Saponaro, Concetta, et al.
Publicado: (2021)

NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer
por: Sonnessa, Margherita, et al.
Publicado: (2020)

Periodontal Pathogens Promote Oral Squamous Cell Carcinoma by Regulating ATR and NLRP3 Inflammasome
por: Yao, Yufei, et al.
Publicado: (2021)

Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial
por: Ibarra-Estrada, Miguel, et al.
Publicado: (2023)

Methylene Blue in the Treatment of Cholera
por: Bryan, John
Publicado: (1952)

Methylene Blue in the Treatment of Cancer
por: Slack, Henry R.
Publicado: (1907)

Acyclovir inhibition of IDO to decrease Tregs as a glioblastoma treatment adjunct
por: Söderlund, Johan, et al.
Publicado: (2010)

Is Myelodysplasia a Consequence of Normal Aging?
por: Heibl, Sonja, et al.
Publicado: (2021)

Compartment syndrome secondary to intra-operative IV methylene blue extravasation to detect ureteral injury
por: AlShammari, Huda, et al.
Publicado: (2023)

Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
por: Liu, Hailiang, et al.
Publicado: (2020)

Methylene blue as adjunctive therapy in septic shock: correct drug diluent derives optimal efficacy
por: Dubey, Dilip, et al.
Publicado: (2023)

Inhibition of the NLRP3 inflammasome prevents ovarian aging
por: Navarro-Pando, José M., et al.
Publicado: (2021)

Inhibition of the NLRP3 inflammasome by HSP90 inhibitors
por: Nizami, Sohaib, et al.
Publicado: (2020)

Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
por: Choudhury, SK Mohiuddin, et al.
Publicado: (2021)

Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
por: Liu, Hailiang, et al.
Publicado: (2021)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

Methylene Blue: Revisited
por: Ginimuge, Prashant R., et al.
Publicado: (2010)

Methylene-Blue in Fevers
por: Frost, G. H.
Publicado: (1908)

Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke
por: Feng, Ya-Shuo, et al.
Publicado: (2020)

Fluoxetine Inhibits NLRP3 Inflammasome Activation: Implication in Depression
por: Du, Ren-Hong, et al.
Publicado: (2016)

Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome
por: Zhou, Wei, et al.
Publicado: (2017)

Structure–Stability Relationship of NLRP3 Inflammasome-Inhibiting Sulfonylureas
por: Keuler, Tim, et al.
Publicado: (2022)

Methylene Blue Inhibits Caspases by Oxidation of the Catalytic Cysteine
por: Pakavathkumar, Prateep, et al.
Publicado: (2015)

Solving the Mystery of Myelodysplasia
por: Radich, Jerald
Publicado: (2008)

Temozolomide-Induced Myelodysplasia
por: Natelson, Ethan A., et al.
Publicado: (2010)

Targeting the NLRP3 Inflammasome in Glaucoma
por: Coyle, Sophie, et al.
Publicado: (2021)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2018)

Paint It Blue: Methylene Blue in Burn Care
por: Goodenough, Christopher J., et al.
Publicado: (2020)

The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
por: Hooftman, Alexander, et al.
Publicado: (2020)

Hsp90 inhibition as a means to inhibit activation of the NLRP3 inflammasome
por: Piippo, Niina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o0s731iqt8c1aguaiupvo71774